Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.17	108.56	91.87
Graham Fair Price	0.13	10.11	10.10
PEG	0.00	0.00	0.00
Price/Book	14.23	5.02	4.39
Price/Cash Flow	905.60	-1234.54	122.77
Prices/Earnings	21.17	50.81	41.94
Price/Sales	14.04	25.93	22.74
Price/FCF	905.60	-1234.54	122.77
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.81	0.69	0.69
Operating Margin	14.63	0.18	0.16
ROA	-6.65	0.01	0.01
ROE	0.03	0.02	-5.72
ROIC	0.02	0.02	-10.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.16	0.02	665.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.16	0.19	18.66
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.40	-1.12	177.65
Revenue QOQ	0.06	0.04	-37.36
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	194.91	190.65	-2.19
Days Sales Outstanding (DSO)	53.83	53.78	-0.10
Inventory Turnover	0.46	0.47	2.24
Debt/Capitalization	0.33	0.36	7.83
Quick Ratio	0.63	1.29	106.43
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.16	13.57	3.12
Cash	0.59	2.76	368.26
Capex	-0.18	-0.17	8.43
Free Cash Flow	0.47	-0.06	-88.29
Revenue	2.54	2.63	3.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.32	1.66	26.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.49	8.66	2.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating